Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + DA-EPOCH-R in c-myc+ DLBCL
NCT02815397Phase 2Terminated
- Sponsor
- Rush University Medical Center
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in diffuse large B-cell lymphoma (DLBCL), sponsored by Rush University Medical Center. Started Feb 2016; status: terminated.
02
Drugs
metformin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02815397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02815397.